EHWM
BIIB icon

Eads & Heald Wealth Management’s Biogen BIIB Stock Holding History

Eads & Heald Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-761
Closed -$215K – 147
2021
Q3 		$215K Buy
+761
New +$249K 0.1% 139
2019
Q1 		– Sell
-805
Closed -$242K – 127
2018
Q4 		$242K Hold
805
– – 0.16% 118
2018
Q3 		$284K Sell
805
-30
-4% -$10.3K 0.16% 117
2018
Q2 		$242K Sell
835
-33
-4% -$9.28K 0.15% 121
2018
Q1 		$238K Buy
868
+78
+10% +$24.2K 0.15% 119
2017
Q4 		$252K Sell
790
-90
-10% -$28.9K 0.15% 118
2017
Q3 		$276K Sell
880
-136
-13% -$40.3K 0.17% 117
2017
Q2 		$276K Sell
1,016
-165
-14% -$43.6K 0.18% 116
2017
Q1 		$323K Sell
1,181
-30
-2% -$8.48K 0.21% 114
2016
Q4 		$343K Sell
1,211
-274
-18% -$81.2K 0.23% 115
2016
Q3 		$465K Sell
1,485
-300
-17% -$88.9K 0.32% 106
2016
Q2 		$432K Sell
1,785
-270
-13% -$71.2K 0.3% 107
2016
Q1 		$535K Buy
2,055
+65
+3% +$17.2K 0.37% 102
2015
Q4 		$610K Sell
1,990
-230
-10% -$66.1K 0.42% 95
2015
Q3 		$648K Buy
2,220
+15
+0.7% +$4.95K 0.46% 89
2015
Q2 		$891K Buy
2,205
+387
+21% +$155K 0.59% 78
2015
Q1 		$768K Sell
1,818
-149
-8% -$58.7K 0.49% 84
2014
Q4 		$668K Sell
1,967
-35
-2% -$11.3K 0.42% 97
2014
Q3 		$662K Buy
2,002
+480
+32% +$158K 0.45% 89
2014
Q2 		$480K Buy
1,522
+110
+8% +$33.1K 0.32% 100
2014
Q1 		$432K Buy
1,412
+209
+17% +$66.3K 0.28% 101
2013
Q4 		$336K Buy
1,203
+260
+28% +$67.2K 0.22% 106
2013
Q3 		$227K Sell
943
-285
-23% -$63.8K 0.16% 111
2013
Q2 		$264K Buy
+1,228
New +$262K 0.19% 106

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Eads & Heald Wealth Management's BIIB Position: Q4 2021 in Review

Eads & Heald Wealth Management sold out of Biogen (BIIB) in Q4 2021, closing a stake of 761 shares — an estimated $215K sold.

Eads & Heald Wealth Management first reported a position in BIIB in Q2 2013 and held it in 24 quarters. The position peaked at $891K in Q2 2015. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q4 2021.

  • Eads & Heald Wealth Management reported no remaining Biogen position as of Q4 2021 after selling out during the quarter.
  • Eads & Heald Wealth Management sold 761 Biogen shares in Q4 2021, an estimated $215K.
  • Eads & Heald Wealth Management first reported a position in Biogen in Q2 2013 and held it in 24 quarters.
  • Eads & Heald Wealth Management's Biogen position peaked at $891K in Q2 2015.
  • 1,009 funds tracked by Wall St. Rank held Biogen as of Q4 2021.

Based on Eads & Heald Wealth Management's 13F filing for Q4 2021, filed 31 Jan 2022.